Related Experiment Video

Updated: Aug 14, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Blocking leukocyte influx and function to prevent chronic lung disease of prematurity

Richard L Auten1, Ikechukwu I Ekekezie

  • 1Neonatal-Perinatal Research Institute, Division of Neonatal Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. auten@duke.edu

Pediatric Pulmonology
|April 11, 2003
PubMed

Insights

Inflammation contributes to chronic lung disease of prematurity (CLD). New strategies targeting specific inflammatory pathways may offer safer treatments than current options like glucocorticoids.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Medicine
  • Inflammation Research

Background:

  • Inflammation is a key factor in the development of chronic lung disease of prematurity (CLD).
  • Premature infants have underdeveloped antioxidant defenses, making them susceptible to oxygen-induced lung injury.
  • Mechanical stress in surfactant-deficient lungs exacerbates cellular injury and inflammation.

Purpose of the Study:

  • To explore the role of inflammation in CLD pathogenesis.
  • To evaluate the limitations of current anti-inflammatory treatments.
  • To identify novel therapeutic strategies for managing lung inflammation in premature infants.

Main Methods:

  • Review of existing literature on inflammation and CLD.
  • Analysis of inflammatory pathways involved in neonatal lung injury.
  • Assessment of the efficacy and risks of glucocorticoids.

Main Results:

  • Inflammation is present at birth in infants who develop CLD.
  • Glucocorticoids are associated with significant risks and limited net benefit.
  • Targeting specific inflammatory pathways presents a promising alternative.

Conclusions:

  • Current anti-inflammatory treatments for CLD are limited.
  • More targeted approaches to inflammation blockade are needed.
  • Future strategies may allow for personalized treatment of neonatal lung inflammation.

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...